866-997-4948(US-Canada Toll Free)

United States Recombinant Glycosylated Protein Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 97 Pages

In this report, the United States Recombinant Glycosylated Protein market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Recombinant Glycosylated Protein in these regions, from 2012 to 2022 (forecast).

United States Recombinant Glycosylated Protein market competition by top manufacturers/players, with Recombinant Glycosylated Protein sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Novartis International AG
Hospira Inc
Celltrion Pharma Inc
Biocon Limited
Teva Pharmaceutical Industries Ltd
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Insulin
rHGH
Interferon
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Recombinant Glycosylated Protein for each application, including
Blood & Oncology Diseases
Chronic Diseases
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Recombinant Glycosylated Protein Market Report 2017
1 Recombinant Glycosylated Protein Overview
1.1 Product Overview and Scope of Recombinant Glycosylated Protein
1.2 Classification of Recombinant Glycosylated Protein by Product Category
1.2.1 United States Recombinant Glycosylated Protein Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Recombinant Glycosylated Protein Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Insulin
1.2.4 rHGH
1.2.5 Interferon
1.3 United States Recombinant Glycosylated Protein Market by Application/End Users
1.3.1 United States Recombinant Glycosylated Protein Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Blood & Oncology Diseases
1.3.3 Chronic Diseases
1.3.4 Others
1.4 United States Recombinant Glycosylated Protein Market by Region
1.4.1 United States Recombinant Glycosylated Protein Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.4.3 Southwest Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.4.5 New England Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.4.6 The South Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.4.7 The Midwest Recombinant Glycosylated Protein Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Recombinant Glycosylated Protein (2012-2022)
1.5.1 United States Recombinant Glycosylated Protein Sales and Growth Rate (2012-2022)
1.5.2 United States Recombinant Glycosylated Protein Revenue and Growth Rate (2012-2022)

2 United States Recombinant Glycosylated Protein Market Competition by Players/Suppliers
2.1 United States Recombinant Glycosylated Protein Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Recombinant Glycosylated Protein Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Recombinant Glycosylated Protein Average Price by Players/Suppliers (2012-2017)
2.4 United States Recombinant Glycosylated Protein Market Competitive Situation and Trends
2.4.1 United States Recombinant Glycosylated Protein Market Concentration Rate
2.4.2 United States Recombinant Glycosylated Protein Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Recombinant Glycosylated Protein Manufacturing Base Distribution, Sales Area, Product Type

3 United States Recombinant Glycosylated Protein Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Recombinant Glycosylated Protein Sales and Market Share by Region (2012-2017)
3.2 United States Recombinant Glycosylated Protein Revenue and Market Share by Region (2012-2017)
3.3 United States Recombinant Glycosylated Protein Price by Region (2012-2017)

4 United States Recombinant Glycosylated Protein Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Recombinant Glycosylated Protein Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Recombinant Glycosylated Protein Revenue and Market Share by Type (2012-2017)
4.3 United States Recombinant Glycosylated Protein Price by Type (2012-2017)
4.4 United States Recombinant Glycosylated Protein Sales Growth Rate by Type (2012-2017)

5 United States Recombinant Glycosylated Protein Sales (Volume) by Application (2012-2017)
5.1 United States Recombinant Glycosylated Protein Sales and Market Share by Application (2012-2017)
5.2 United States Recombinant Glycosylated Protein Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Recombinant Glycosylated Protein Players/Suppliers Profiles and Sales Data
6.1 Novartis International AG
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Recombinant Glycosylated Protein Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Novartis International AG Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Hospira Inc
6.2.2 Recombinant Glycosylated Protein Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Hospira Inc Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Celltrion Pharma Inc
6.3.2 Recombinant Glycosylated Protein Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Celltrion Pharma Inc Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Biocon Limited
6.4.2 Recombinant Glycosylated Protein Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Biocon Limited Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Teva Pharmaceutical Industries Ltd
6.5.2 Recombinant Glycosylated Protein Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
...

7 Recombinant Glycosylated Protein Manufacturing Cost Analysis
7.1 Recombinant Glycosylated Protein Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Glycosylated Protein

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Recombinant Glycosylated Protein Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Glycosylated Protein Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Recombinant Glycosylated Protein Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Recombinant Glycosylated Protein Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Recombinant Glycosylated Protein Sales Volume Forecast by Type (2017-2022)
11.3 United States Recombinant Glycosylated Protein Sales Volume Forecast by Application (2017-2022)
11.4 United States Recombinant Glycosylated Protein Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Recombinant Glycosylated Protein
Figure United States Recombinant Glycosylated Protein Market Size (K MT) by Type (2012-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume Market Share by Type (Product Category) in 2016
Figure Insulin Product Picture
Figure rHGH Product Picture
Figure Interferon Product Picture
Figure United States Recombinant Glycosylated Protein Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Recombinant Glycosylated Protein by Application in 2016
Figure Blood & Oncology Diseases Examples
Table Key Downstream Customer in Blood & Oncology Diseases
Figure Chronic Diseases Examples
Table Key Downstream Customer in Chronic Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Recombinant Glycosylated Protein Market Size (Million USD) by Region (2012-2022)
Figure The West Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Glycosylated Protein Sales (K MT) and Growth Rate (2012-2022)
Figure United States Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Recombinant Glycosylated Protein Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Recombinant Glycosylated Protein Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Recombinant Glycosylated Protein Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Glycosylated Protein Sales Share by Players/Suppliers
Figure 2017 United States Recombinant Glycosylated Protein Sales Share by Players/Suppliers
Figure United States Recombinant Glycosylated Protein Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Recombinant Glycosylated Protein Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Recombinant Glycosylated Protein Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Recombinant Glycosylated Protein Revenue Share by Players/Suppliers
Figure 2017 United States Recombinant Glycosylated Protein Revenue Share by Players/Suppliers
Table United States Market Recombinant Glycosylated Protein Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Recombinant Glycosylated Protein Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Recombinant Glycosylated Protein Market Share of Top 3 Players/Suppliers
Figure United States Recombinant Glycosylated Protein Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Recombinant Glycosylated Protein Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Recombinant Glycosylated Protein Product Category
Table United States Recombinant Glycosylated Protein Sales (K MT) by Region (2012-2017)
Table United States Recombinant Glycosylated Protein Sales Share by Region (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Share by Region (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Market Share by Region in 2016
Table United States Recombinant Glycosylated Protein Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Recombinant Glycosylated Protein Revenue Share by Region (2012-2017)
Figure United States Recombinant Glycosylated Protein Revenue Market Share by Region (2012-2017)
Figure United States Recombinant Glycosylated Protein Revenue Market Share by Region in 2016
Table United States Recombinant Glycosylated Protein Price (USD/MT) by Region (2012-2017)
Table United States Recombinant Glycosylated Protein Sales (K MT) by Type (2012-2017)
Table United States Recombinant Glycosylated Protein Sales Share by Type (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Share by Type (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Market Share by Type in 2016
Table United States Recombinant Glycosylated Protein Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Recombinant Glycosylated Protein Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Glycosylated Protein by Type (2012-2017)
Figure Revenue Market Share of Recombinant Glycosylated Protein by Type in 2016
Table United States Recombinant Glycosylated Protein Price (USD/MT) by Types (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Growth Rate by Type (2012-2017)
Table United States Recombinant Glycosylated Protein Sales (K MT) by Application (2012-2017)
Table United States Recombinant Glycosylated Protein Sales Market Share by Application (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Market Share by Application (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Market Share by Application in 2016
Table United States Recombinant Glycosylated Protein Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Glycosylated Protein Sales Growth Rate by Application (2012-2017)
Table Novartis International AG Basic Information List
Table Novartis International AG Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis International AG Recombinant Glycosylated Protein Sales Growth Rate (2012-2017)
Figure Novartis International AG Recombinant Glycosylated Protein Sales Market Share in United States (2012-2017)
Figure Novartis International AG Recombinant Glycosylated Protein Revenue Market Share in United States (2012-2017)
Table Hospira Inc Basic Information List
Table Hospira Inc Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hospira Inc Recombinant Glycosylated Protein Sales Growth Rate (2012-2017)
Figure Hospira Inc Recombinant Glycosylated Protein Sales Market Share in United States (2012-2017)
Figure Hospira Inc Recombinant Glycosylated Protein Revenue Market Share in United States (2012-2017)
Table Celltrion Pharma Inc Basic Information List
Table Celltrion Pharma Inc Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Celltrion Pharma Inc Recombinant Glycosylated Protein Sales Growth Rate (2012-2017)
Figure Celltrion Pharma Inc Recombinant Glycosylated Protein Sales Market Share in United States (2012-2017)
Figure Celltrion Pharma Inc Recombinant Glycosylated Protein Revenue Market Share in United States (2012-2017)
Table Biocon Limited Basic Information List
Table Biocon Limited Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Biocon Limited Recombinant Glycosylated Protein Sales Growth Rate (2012-2017)
Figure Biocon Limited Recombinant Glycosylated Protein Sales Market Share in United States (2012-2017)
Figure Biocon Limited Recombinant Glycosylated Protein Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Glycosylated Protein
Figure Manufacturing Process Analysis of Recombinant Glycosylated Protein
Figure Recombinant Glycosylated Protein Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Glycosylated Protein Major Players/Suppliers in 2016
Table Major Buyers of Recombinant Glycosylated Protein
Table Distributors/Traders List
Figure United States Recombinant Glycosylated Protein Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Glycosylated Protein Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Recombinant Glycosylated Protein Price (USD/MT) Trend Forecast (2017-2022)
Table United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Type in 2022
Table United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Application in 2022
Table United States Recombinant Glycosylated Protein Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Recombinant Glycosylated Protein Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume Share Forecast by Region (2017-2022)
Figure United States Recombinant Glycosylated Protein Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *